Overview

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Status:
Recruiting
Trial end date:
2025-07-31
Target enrollment:
Participant gender:
Summary
This research study is studying a topical ointment called calcipotriene to see if it can stimulate the immune cells against the breast lesion in ways that would prevent its recurrence after surgical removal
Phase:
Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Calcipotriene
Calcitriol
Petrolatum